Heininger U, Seward JF. Varicella. Lancet. 2006;368:1365–76.
Bonhoeffer J, Baer G, Mühleisen B, Aebi C, Nadal D, Schaad UB et al. Prospective surveillance of hospitalisations associated with varicella-zoster virus infections in children and adolescents. Eur J Pediatr. 2005;164:366–70.
Heininger U, Braun-Fahrländer C, Desgrandchamps D, Glaus J, Grize L, Wutzler P, et al. Seroprevalence of varicella-zoster virus immunoglobulin G antibodies in Swiss adolescents and risk factor analysis for seronegativity. Pediatr Infect Dis J. 2001;20:775–8.
Marin M, Marti M, Kambhampati A, Jeram SM, Seward JF. Global Varicella Vaccine Effectiveness: A Meta-analysis. Pediatrics. 2016;137:e20153741
Heininger U, Baer G, Bonhoeffer J, Schaad UB. Reliability of varicella history in children and adolescents. Swiss Med Wkly. 2005;135:252–5.
Freuler M, De Crom S, Hatz C, Bühler S. Varicella seroprevalence in individuals with a negative or unknown varicella history – results from a large Travel Clinic in Switzerland between 2008 and 2015. Swiss Med Wkly. 2016;146:w14342 http://www.smw.ch/content/smw-2016-14342.
Ronan K, Wallace MR. The utility of serologic testing for varicella in an adolescent population. Vaccine. 2001;19:4700–2.
Lopez AS, Zhang J, Brown C, Bialek S. Varicella-related hospitalizations in the United States, 2000–2006: the 1-dose varicella vaccination era. Pediatrics. 2011;127:238–45.
Khandaker G, Marshall H, Peadon E, Zurynski Y, Burgner D, Buttery J et al. Congenital and neonatal varicella: impact of the national varicella vaccination programme in Australia. Arch Dis Child. 2011;96:453–6.
Streng A, Grote V, Carr D, Hagemann C, Liese JG. Varicella routine vaccination and the effects on varicella epidemiology – results from the Bavarian Varicella Surveillance Project (BaVariPro), 2006–2011. BMC Infect Dis. 2013;13:303.